BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 12160846)

  • 1. Absence of donor-derived keratinocyte stem cells in skin tissues cultured from patients after mobilized peripheral blood hematopoietic stem cell transplantation.
    Hematti P; Sloand EM; Carvallo CA; Albert MR; Yee CL; Fuehrer MM; Blancato JK; Kearns WG; Barrett JA; Childs RW; Vogel JC; Dunbar CE
    Exp Hematol; 2002 Aug; 30(8):943-9. PubMed ID: 12160846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progenipoietin-1: a multifunctional agonist of the granulocyte colony-stimulating factor receptor and fetal liver tyrosine kinase-3 is a potent mobilizer of hematopoietic stem cells.
    Fleming WH; Mulcahy JM; McKearn JP; Streeter PR
    Exp Hematol; 2001 Aug; 29(8):943-51. PubMed ID: 11495700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial.
    Lonial S; Akhtari M; Kaufman J; Torre C; Lechowicz MJ; Flowers C; Sinha R; Khoury HJ; Langston AA; Waller EK
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):460-7. PubMed ID: 23201472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases].
    Chen Y; Huang X; Xu L; Liu D; Zhang Y; Ren H; Guo N; Lu D
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1306-9. PubMed ID: 12509932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis.
    Bornhäuser M; Theuser C; Soucek S; Hölig K; Klingebiel T; Blau W; Fauser A; Runde V; Schwinger W; Rutt C; Ehninger G
    Haematologica; 2000 Aug; 85(8):839-47. PubMed ID: 10942931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic stem cell origin of human fibroblasts: cell culture studies of female recipients of gender-mismatched stem cell transplantation and patients with chronic myelogenous leukemia.
    Shirai K; Sera Y; Bulkeley W; Mehrotra M; Moussa O; LaRue AC; Watson DK; Stuart RK; Lazarchick J; Ogawa M
    Exp Hematol; 2009 Dec; 37(12):1464-71. PubMed ID: 19786066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Tolerance Toward Haploidentical Vascularized Composite Allograft Transplantation in a Canine Model Using Bone Marrow or Mobilized Stem Cells.
    Chang J; Graves SS; Butts-Miwongtum T; Sale GE; Storb R; Mathes DW
    Transplantation; 2016 Dec; 100(12):e120-e127. PubMed ID: 27861292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graft monocytic myeloid-derived suppressor cell content predicts the risk of acute graft-versus-host disease after allogeneic transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood stem cells.
    Vendramin A; Gimondi S; Bermema A; Longoni P; Rizzitano S; Corradini P; Carniti C
    Biol Blood Marrow Transplant; 2014 Dec; 20(12):2049-55. PubMed ID: 25246295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-time quantitative Y chromosome-specific PCR (QYCS-PCR) for monitoring hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation.
    Fehse B; Chukhlovin A; Kühlcke K; Marinetz O; Vorwig O; Renges H; Krüger W; Zabelina T; Dudina O; Finckenstein FG; Kröger N; Kabisch H; Hochhaus A; Zander AR
    J Hematother Stem Cell Res; 2001 Jun; 10(3):419-25. PubMed ID: 11454317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor-derived type II pneumocytes are rare in the lungs of allogeneic hematopoietic cell transplant recipients.
    Zander DS; Cogle CR; Theise ND; Crawford JM
    Ann Clin Lab Sci; 2006; 36(1):47-52. PubMed ID: 16501236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte-mobilized bone marrow.
    Arcese W; De Angelis G; Cerretti R
    Curr Opin Hematol; 2012 Nov; 19(6):448-53. PubMed ID: 22954729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of recipient-type endothelium after allogeneic hematopoietic stem cell transplantation.
    Mueller RJ; Stussi G; Puga Yung G; Nikolic M; Soldini D; Halter J; Meyer-Monard S; Gratwohl A; Passweg JR; Odermatt B; Schanz U; Biedermann BC; Seebach JD
    Haematologica; 2011 Jan; 96(1):119-27. PubMed ID: 20934999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells.
    Körbling M; Katz RL; Khanna A; Ruifrok AC; Rondon G; Albitar M; Champlin RE; Estrov Z
    N Engl J Med; 2002 Mar; 346(10):738-46. PubMed ID: 11882729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic peripheral blood stem cell transplantation and early detection of donor engraftment by polymerase chain reaction.
    Tzeng CH; Lyou JY; Lin JS; Chen YR; Hu HY; Yung CH; Wang SY; Lee JC
    J Formos Med Assoc; 1998 Apr; 97(4):252-60. PubMed ID: 9585676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryopreservation of hematopoietic stem/progenitor cells for therapeutic use.
    Watt SM; Austin E; Armitage S
    Methods Mol Biol; 2007; 368():237-59. PubMed ID: 18080475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic graft-versus-host disease after granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation: the role of donor T-cell dose and differentiation.
    MacDonald KP; Rowe V; Filippich C; Johnson D; Morris ES; Clouston AD; Ferrara JL; Hill GR
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):373-85. PubMed ID: 15148491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte-colony stimulating factor primed bone marrow and granulocyte-colony stimulating factor mobilized peripheral blood stem cells are equivalent for engraftment: which to choose?
    Elfenbein GJ
    Pediatr Transplant; 2005 Dec; 9 Suppl 7():37-47. PubMed ID: 16305616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Randomized clinical study for two types of recombinant human granulocyte colony-stimulating factor mobilizing peripheral blood and bone marrow stem cells in patients receiving allogeneic hematopoietic stem cell transplantation].
    Zhang XH; Huang XJ; Liu DH; Liu KY; Han W; Chen H; Wang FR; Chen YH; Wang JZ; Zhao T; Wang Y; Xu LP
    Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2116-9. PubMed ID: 20058615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model.
    Hartung G; Zeis M; Glass B; Dreger P; Steinmann J; Schmitz N; Uharek L
    Bone Marrow Transplant; 2003 Jul; 32(1):49-56. PubMed ID: 12815478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of microchimerism in pediatric patients after living-related liver transplantation.
    Ueda M; Hundrieser J; Hisanaga M; Tanaka K; Wonigeit K; Pichlmayr R; Schlitt HJ; Yamaoka Y
    Clin Transplant; 1997 Jun; 11(3):193-200. PubMed ID: 9193841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.